Coronary embolization in hypertrophic cardiomyopathy with left ventricular apical aneurysm

Am J Cardiol. 2015 May 1;115(9):1318-9. doi: 10.1016/j.amjcard.2015.02.016. Epub 2015 Feb 12.

Abstract

Patients with left ventricular apical aneurysms represent a unique patient subgroup in the broad clinical spectrum of hypertrophic cardiomyopathy (HC) associated with the risk for sudden death, heart failure, and peripheral thromboembolism. Routine chronic anticoagulation has not been a standard recommendation for these patients. We present a 36-year-old patient with HC with features of acute coronary syndrome, likely secondary to coronary thromboembolism as a complication of left ventricular apical aneurysm. Our experience with this patient raises consideration for prophylactic anticoagulant therapy for this unusual subset of patients with HC.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Cardiomyopathy, Hypertrophic / complications*
  • Embolization, Therapeutic*
  • Heart Aneurysm / complications
  • Heart Aneurysm / diagnosis
  • Heart Aneurysm / therapy*
  • Heart Ventricles
  • Humans
  • Male
  • Thromboembolism / prevention & control

Substances

  • Anticoagulants